Today

Agents

Chat

Arena

Discover

More

App

US FDA sent warning letter to Bausch & Lomb on September 4 - BLCO News | Rallies

US FDA sent warning letter to Bausch & Lomb on September 4

BLCO•2026-09-15

FDA warning letter to Bausch & Lomb

US FDA: sent warning letter to Bausch & Lomb Inc. on Sept. 4 - website
US FDA: warning letter to Bausch & Lomb for significant current good manufacturing practice violations at Tampa drug manufacturing facility

Further company coverage: BLCO.TO

Related News

Everbridge launches Everbridge 360 AI Protective Intelligence product suite

EVBG•2026-09-15

As Trump backs psychedelics research, FDA weighs safety and access standards

CMPS•2026-09-15

Nasdaq trade halt continues <UCFIW.O> reason not available at 09:56 AM

•

2026-09-15

Centerspace <CSR.N>: UBS cuts target price to $68 from $70

CSR•2026-09-15

Otis falls after CEO Marks to retire next year

OTIS•2026-09-15